RxDoctor Payments Data

Maria Sanchez, PA

Physician Assistant · Liberty, TXNPI 1801027149

Payments from drug & device makers

$740in general payments, 2019–2025

Across 34 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$151
  • GSK$124
  • AstraZeneca$88
  • Boehringer Ingelheim$64
  • Novo Nordisk$59
  • Pfizer$48
  • plus $206 from 8 others

What the payments were for

  • Food & beverage$740100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$740 in reported general payments places this provider in the 60th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$41,605
Medicare patients
135
Services billed
1,394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$19,915
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,556
Albuterol Sulfate HfaAlbuterol Sulfate44$1,353
Atorvastatin Calcium126$1,141
Gabapentin55$1,041
Amlodipine Besylate100$692
Duloxetine Hcl29$649
Levothyroxine Sodium76$598
Cefdinir31$583
Metoprolol Succinate38$533
Rosuvastatin Calcium55$508
Lisinopril81$500
Losartan Potassium47$435
Metformin Hcl ErMetformin Hcl29$355
Tamsulosin Hcl30$313

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$64$19,91520 claims
GSKTrelegy Ellipta$124$18,55621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Liberty

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →